- Home
- ACIU vs BBCP Comparison
ACIU vs BBCP Comparison
Compare ACIU & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- BBCP
- Stock Information
- Founded
- ACIU 2003
- BBCP 1983
- Country
- ACIU Switzerland
- BBCP United States
- Employees
- ACIU N/A
- BBCP N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- BBCP Engineering & Construction
- Sector
- ACIU Health Care
- BBCP Consumer Discretionary
- Exchange
- ACIU Nasdaq
- BBCP Nasdaq
- Market Cap
- ACIU 332.4M
- BBCP 370.5M
- IPO Year
- ACIU 2016
- BBCP 2017
- Fundamental
- Price
- ACIU $3.15
- BBCP $7.15
- Analyst Decision
- ACIU Strong Buy
- BBCP Buy
- Analyst Count
- ACIU 2
- BBCP 4
- Target Price
- ACIU $12.00
- BBCP $7.67
- AVG Volume (30 Days)
- ACIU 153.3K
- BBCP 93.4K
- Earning Date
- ACIU 11-05-2024
- BBCP 01-09-2025
- Dividend Yield
- ACIU N/A
- BBCP N/A
- EPS Growth
- ACIU N/A
- BBCP N/A
- EPS
- ACIU N/A
- BBCP 0.26
- Revenue
- ACIU $48,505,404.00
- BBCP $434,594,000.00
- Revenue This Year
- ACIU $85.33
- BBCP N/A
- Revenue Next Year
- ACIU $80.69
- BBCP N/A
- P/E Ratio
- ACIU N/A
- BBCP $27.43
- Revenue Growth
- ACIU 4097200.00
- BBCP N/A
- 52 Week Low
- ACIU $2.25
- BBCP $5.05
- 52 Week High
- ACIU $5.14
- BBCP $8.48
- Technical
- Relative Strength Index (RSI)
- ACIU 45.68
- BBCP 73.87
- Support Level
- ACIU $3.10
- BBCP $7.05
- Resistance Level
- ACIU $3.25
- BBCP $7.37
- Average True Range (ATR)
- ACIU 0.14
- BBCP 0.27
- MACD
- ACIU -0.02
- BBCP 0.11
- Stochastic Oscillator
- ACIU 13.16
- BBCP 88.42
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.